| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |